Under the theme of “Navigating the pharma and healthcare supply chain in these unprecedented times”, JAS recently conducted an important webinar to bring its customers and industry partners together to project the way forward.
Over 30 pharma and healthcare companies representing pharmaceuticals, medical devices, diagnostics, and consumers gained practical and non-sugarcoated insights from this JAS webinar. Topics ranged from the current ocean freight situation to various digital topics - especially centered around transparency, visibility, and security.
“I don’t even look at this as a new norm, but maybe we need to pay attention and have renewed focus on supply chain of pharma and healthcare.”, said Jim Fries, CEO Rx-360, keynote speaker for the event. Jim’s inspirational and encouraging words were the perfect segue to the subsequent panel discussions.
His key messages were:
Moderated by Dina Bunn, VP, Customer Experience Pharma & Healthcare at JAS, the first panel discussion was joined by Hermann Ude, Chairman of the Supervisory Board at Transporean, Saravan Kumar, Co-Founder and CEO at MaxQ, Alexis McCubbin, VP Customer Solutions & Strategic Initiatives EMEA at JAS, and Tom Madzy, CIO at JAS.
Here are some of the memorable remarks from the panelists:
The second panel was on ocean freight, moderated by Frank Cascante, SVP Global Sales Pharma & Healthcare at JAS. The panelists were Bill Duggan, North American Advisor at Eskesen Advisory, Nico Puttfarken, Manager Reefer Products at Hapag-Lloyd, Unai Gallstegi, Director Trade Management Latin America at JAS, and Jesper Jepsen, Director Ocean Freight Americas at JAS.
Here are the highlighted comments by the panelists: